MONTKUSH Review: A Vermont Farm, CBDA, and a Sleep Gummy With 1mg of THC In It
Back to Articles
Guides12 min readAugust 11, 2026

MONTKUSH Review: A Vermont Farm, CBDA, and a Sleep Gummy With 1mg of THC In It

MONTKUSH grows and bottles CBD on its own organic farm in Vermont, with free insured delivery over $80 and a 30-day risk-free window. Its CBDA line is a genuine differentiator; its sleep gummy contains 1mg of THC.

By Med Consumer Watch Team
MONTKUSH grows and bottles its own CBD on an organic farm in Vermont, selling CBDA products, CBD oil drops, gummies, softgels and topicals, organised by benefit — recover, relax, sleep, immune support. Verified terms: free tracked and insured delivery on orders over $80, risk-free for 30 days, a loyalty programme and subscribe-and-save. Prices run $39.99 to $109.99, clustering at $59.99. Two things set it apart, and one of them needs flagging clearly. The genuine differentiator is CBDA — the raw acid form of CBD, which most brands do not sell because it requires avoiding the heat step that converts it. Vertical integration from its own farm is what makes that practical, and "farm-to-bottle" here appears to be a description rather than a slogan. The thing to flag: its best-selling True Sleep gummy contains 1mg of THC per serving, alongside 5mg CBN and 25mg CBD. That is disclosed on the product page, and it is not what most people expect from a CBD brand. If you are drug tested, this matters. This review contains affiliate links and we may earn a commission if you buy through them. The assessment is our own. Verified against MONTKUSH's own pages on August 11, 2026.

CBDA: what it is, and what is actually known

This is the interesting part of the catalogue and it deserves a straight explanation, because almost nobody selling it explains it. What CBDA is. Cannabidiolic acid is what the hemp plant actually produces. CBD barely exists in the living plant. CBDA converts to CBD through decarboxylation — losing a carboxyl group under heat, which happens during drying, extraction, or any heated processing. So a CBDA product is one that has deliberately avoided that heat. That takes control of the whole chain from harvest through extraction, which is why vertical integration matters here specifically and why most brands buying bulk distillate cannot offer it. What the science actually supports — and the honest boundary. The bioavailability finding is the interesting one. Preclinical work has suggested CBDA may be absorbed considerably better than CBD, which is a genuine formulation argument given that CBD's oral bioavailability is poor. This is animal and laboratory data, not human clinical outcomes. Receptor differences exist. CBDA interacts with some targets differently from CBD — including serotonin receptor activity in preclinical anti-nausea work. Interesting; not established in people. What there is not: human clinical trial evidence that CBDA relieves pain, anxiety, nausea or anything else in humans at consumer doses. There is one FDA-approved cannabis-derived prescription drug, for specific seizure disorders, and it is CBD, not CBDA. The honest summary: CBDA is a legitimately different molecule with a plausible bioavailability advantage and essentially no human efficacy data. A brand offering it is doing something technically real. That is not the same as it working better for you, and any claim that it does should be read as marketing. What to ask for: a batch-matched certificate of analysis showing CBDA content specifically — because if the product has been heated at any point, you are buying CBD with a CBDA label. That test result is the whole proposition.
  • Form | What it is | Evidence position
  • CBDA | What the plant makes; acid form | Preclinical bioavailability signal; no human efficacy trials
  • CBD | CBDA after heat (decarboxylation) | One FDA-approved prescription drug, for specific seizures
  • CBN | Degradation product of THC | Marketed for sleep; human evidence thin
  • THC | Intoxicating | Present at 1mg in the True Sleep gummy - will affect drug tests
  • Broad-spectrum | THC removed | The choice if you are tested

Ask for a certificate of analysis showing CBDA specifically, not total cannabinoids. CBDA converts to CBD under heat, so the only way to know a CBDA product is what it says is a lab result showing the acid form is still present in the batch you receive.

The THC in the sleep gummy, and who needs to avoid it

This is the most practically important thing in the review, so it gets its own section. MONTKUSH's best-selling True Sleep gummy is listed as 5mg CBN + 25mg CBD + 1mg THC. The THC is disclosed on the product page. Many buyers will not expect a CBD brand's sleep product to contain THC at all. Why 1mg matters more than it sounds: Drug testing. Standard workplace urine screening detects THC metabolites. 1mg per gummy, taken nightly, accumulates — THC metabolites are fat-soluble and clear slowly, over days to weeks with regular use. If you are subject to workplace, athletic, custody, probation or safety-sensitive testing, do not take this product. MONTKUSH also sells a broad-spectrum, THC-free line (True Daily 50mg), which is the correct choice if testing applies to you. It is a real pharmacological dose for some people. 1mg is low, and it is not nothing — particularly in someone THC-naive, elderly, or taking sedating medication. It is intoxicating in principle, which affects the legal position in states that restrict hemp-derived THC. And the federal change on the horizon. P.L. 119-37 redefines hemp effective November 12, 2026, excluding products containing more than 0.4 mg of total THC per container. (Congressional Research Service, IF13136 and LSB11381.) A 30-count gummy jar at 1mg each contains 30mg of THC per container — around 75 times that cap. Excluded products are regulated under the Controlled Substances Act as marijuana. So the practical position on this specific product: it is a well-formulated sleep gummy today, it is not suitable for anyone who is drug tested, and its formulation is directly affected by a change three months away. The brand's non-intoxicating CBD and CBDA lines are far less exposed. On CBN for sleep, briefly. CBN is a degradation product of THC, widely marketed as sedating. The human evidence for CBN as a sleep aid is thin — the reputation traces largely to older, poorly controlled observations. It may help; it is not established. If you have persistent insomnia, CBT-I is the first-line treatment with the best long-term evidence.

MONTKUSH's True Sleep gummy contains 1mg of THC per serving. It can and will cause positive drug tests, particularly with nightly use, as THC metabolites accumulate and clear slowly. If you are subject to workplace, athletic, custody or probation testing, choose the broad-spectrum THC-free products instead. Do not use THC-containing products if pregnant or breastfeeding, and do not drive after taking one.

The farm, the pricing and what to verify

The vertical integration claim is the brand's strongest asset, and it is the kind of claim worth taking seriously because it is checkable. What the site states: grown on their own organic farm in Vermont, USA, with full control from cultivation to bottle, positioned against brands that buy bulk extract of unknown provenance. Why that genuinely matters in CBD. A large share of the CBD market is white-labelled: brands buy bulk distillate from the same handful of processors, add a label and a story. A company that grows, extracts and bottles controls what most brands cannot — cultivar selection, harvest timing, drying conditions, and crucially the heat exposure that determines whether CBDA survives. It is also the only structure under which a CBDA line is straightforward to produce. What to verify rather than assume: Organic certification. "Organic farm" and "USDA Certified Organic" are different claims. Ask which certifier, and for the certificate number. Batch-matched certificates of analysis covering cannabinoid profile (including CBDA specifically), pesticides, heavy metals, residual solvents and microbials, from an accredited third-party lab. What "risk-free for 30 days" actually means. Is it a full refund, is it store credit, do you return the product, and who pays return shipping? Thirty days is a reasonable window for CBD — long enough to assess — and the terms are what make it useful. Pricing. $39.99 to $109.99, with $59.99 the common point and a 60-count option at $109.99 saving around 9%. This is upper-mid market for CBD. As always, compare on cost per milligram, not price per bottle — a 50mg-per-serving product at $59.99 for 30 count is $0.04 per mg, which is competitive. Free tracked and insured delivery over $80 is a slightly unusual and welcome detail — insured shipping is not standard in this category and matters if a parcel goes missing. And the general CBD safety points that apply to everything here: CBD interacts with prescription medicines through the liver enzymes that metabolise many of them, high-dose trials have recorded liver enzyme elevations, and no CBD product is FDA-approved to treat anxiety, pain or insomnia. Tell your prescriber.

Compare CBD on cost per milligram rather than price per bottle. At $59.99 for thirty 50mg servings, MONTKUSH's daily product works out at roughly four cents per milligram - which is the number that lets you compare it fairly against any other brand.

Frequently asked questions

What does MONTKUSH cost? $39.99 to $109.99, with $59.99 the most common price point. Free tracked and insured delivery over $80. What is the return policy? The site advertises risk-free for 30 days. Confirm whether it is a full refund or credit, whether the product must be returned, and who pays return shipping. What is CBDA? The acid form the plant actually produces, which converts to CBD under heat. Preclinical work suggests it may absorb better than CBD, but there is no human clinical efficacy evidence. Is CBDA better than CBD? It is genuinely a different molecule with a plausible bioavailability advantage. That is not the same as demonstrated benefit in people. Does MONTKUSH contain THC? Some products do. The True Sleep gummy is listed at 5mg CBN + 25mg CBD + 1mg THC. The True Daily broad-spectrum line is stated as THC-free. Will it fail a drug test? The THC-containing products will, especially with nightly use. Choose the broad-spectrum THC-free line if you are tested — and note that even broad-spectrum carries a small residual risk. Does the November 2026 hemp law affect it? The federal hemp definition excludes products over 0.4mg total THC per container from November 12, 2026. A 30-count jar at 1mg per gummy is far over that. The non-intoxicating CBD and CBDA lines are much less exposed. Does CBN help you sleep? The human evidence is thin. CBT-I is the first-line treatment for persistent insomnia. Is it really grown in Vermont? That is the company's stated position and the basis of its farm-to-bottle claim. Ask for the organic certifier and certificate number to verify the organic part. Can I take CBD with my medication? Ask your prescriber first. CBD interacts with several drug classes through liver enzymes.

The Bottom Line

Our rating: 7.5 / 10. One of the few CBD brands doing something technically distinctive, with one product that needs a clearer warning than it gets. The farm-to-bottle structure is the real asset. A large share of the CBD market is the same bulk distillate under different labels; a company that grows, extracts and bottles controls cultivar, harvest, drying and — critically — heat exposure. That last one is what makes the CBDA line possible, and CBDA is a legitimately different molecule with a plausible bioavailability advantage that most brands simply cannot offer. A 30-day risk-free window is appropriate for a product assessed over weeks, and free tracked and insured delivery over $80 is a small detail that is better than the category norm. Two honest caveats. CBDA has essentially no human efficacy data — preclinical bioavailability findings are interesting and are not clinical outcomes, and any suggestion that it works better in people goes beyond the evidence. Ask for a batch COA showing CBDA specifically, because that lab result is the entire proposition. And the sleep gummy needs saying plainly: it contains 1mg of THC per serving. That is disclosed, and it will still surprise buyers who assume a CBD brand's sleep product is THC-free. If you are drug tested in any context, buy the broad-spectrum THC-free line instead — nightly 1mg doses accumulate. That product is also the one most exposed to the November 12, 2026 federal change, since a 30-count jar holds around 75 times the new 0.4mg-per-container cap. Buy from here if you want CBD from a brand that actually controls its supply chain, and the CBDA line interests you. Read the label on the sleep products, ask for the COA, and tell your prescriber. Check MONTKUSH's current range and pricing Informational only, not medical advice. Prices, shipping thresholds and guarantee terms verified as published August 11, 2026 and subject to change. CBD and CBDA products are not FDA-approved to diagnose, treat, cure or prevent any disease; one cannabis-derived prescription drug is approved for specific seizure disorders. CBD interacts with several prescription medicines and high doses have been associated with liver enzyme elevations - consult a clinician before use. THC-containing products cause positive drug tests, must not be used before driving, and are not for use in pregnancy or breastfeeding. Federal hemp law changes on November 12, 2026 per P.L. 119-37; state law varies. Keep away from children. 21+ where required.

Medical Disclaimer

This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.

Enter to Win a $1,788 CoreAge Rx Gift Card

Enter for a chance to use it toward eligible CoreAge Rx products and services.

The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.

No purchase necessary. Prescription products require provider evaluation and approval. See Official Rules. Official Rules · Gift Card Terms · Privacy Policy · Terms